Newton, D L <br/><br/>
Specifically targeting the CD22 receptor of human B-cell lymphomas with RNA damaging agents.  [electronic resource] 

 -  Critical reviews in oncology/hematology   
 - 79-86 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.; Review 
<br/><br/><label>ISSN: </label>1040-8428 
<br/><br/><label>Standard No.: </label>10.1016/s1040-8428(01)00116-0  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibodies, Monoclonal--therapeutic use<br/>Antigens, CD--immunology<br/>Antigens, Differentiation, B-Lymphocyte--immunology<br/>Antigens, Neoplasm--immunology<br/>Cell Adhesion Molecules<br/>Humans<br/>Immunotoxins--chemistry<br/>Lectins<br/>Lymphoma, B-Cell--drug therapy<br/>RNA--metabolism<br/>Ribonucleases--therapeutic use<br/>Sialic Acid Binding Ig-like Lectin 2